About: Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology. Its lead drug candidate is stenoparib, a dual inhibitor of poly-ADP-ribose polymerase (PARP1/2), which is in a Phase 2 clinical trial for patients with advanced and recurrent ovarian cancer. It is also developing stenoparib with temozolomide, a PARP and WNT inhibitor in combination with a DNA-alkylating chemotherapy agent, which is in a Phase 2 clinical trial for patients with relapsed small cell lung cancer; and stenoparib-DRP, a companion diagnostic product used to select patients for stenoparib treatment. Allarity Therapeutics, Inc. is headquartered in Tarpon Springs, Florida.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.89 (-4.09%)
ALLR NASDAQ Allarity Therapeutics Inc
Allarity Therapeutics Inc share price
Atividade de preço de ALLR
Último preço
$ 0,890
Variação (24h)
-0,04 USD (4,09%)
Volume
150.03K
Volume (média 4 sem.)
-
Abertura
$ 0,94
Variação do dia
$ 0,85 - $ 0,94
Fechamento anterior
$ 0,93
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
ALLR price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals